Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The purpose of this research study is to investigate the safety and feasibility of two (2) oral doses of psilocybin when combined with behavioral support for methamphetamine use disorder (MUD). Participants have a diagnosis of methamphetamine use disorder (MUD). Participants can expect to be actively engaged in the study for up to 26 weeks.
Epistemonikos ID: f363989f6f0057dc5dfdf40cc7faae32d43b8094
First added on: May 13, 2024